Dechra Pharmaceuticals PLC (DPH.L)
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|2016||Non-Executive Chairman of the Board|
|2001||Chief Executive Officer, Executive Director|
|56||2017||Chief Financial Officer, Executive Director|
|2015||President, North America|
|51||2012||Managing Director - Dechra Veterinary Products Europe, Executive Director|
- 4 perfect stocks for 'Brexit Britain'!
- Are RhythmOne plc, Dechra Pharmaceuticals plc and Pagegroup plc 'buys' after today's updates?
- Should you be buying AstraZeneca plc, Alliance Pharma plc and Dechra Pharmaceuticals plc today?
- Should You Buy Dechra Pharmaceuticals plc, Enquest Plc & Cairn Energy PLC Today?
- Are GlaxoSmithKline plc, Dechra Pharmaceuticals plc & CareTech Holdings plc On The Cusp Of Stunning Returns?
- 4 Great Growth Picks For 2016 And Beyond: Barclays PLC, Dechra Pharmaceuticals plc, Britvic Plc And Marks & Spencer Group Plc